Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Aug;41(2):822–825. doi: 10.1128/iai.41.2.822-825.1983

Action of different gamma interferons on mouse leukemic cells resistant to alpha and beta interferons.

F Besançon, J Wietzerbin, S Stefanos, J Wietzerbin, E Falcoff
PMCID: PMC264713  PMID: 6409814

Abstract

Phytohemagglutinin-induced interferon-gamma (IFN-gamma) was reported to act on mouse leukemic L1210 R cells resistant to IFN-alpha and -beta. Results reported here show that these cells are also sensitive to various preparations of murine IFN-gamma derived from different sources and purified to different degrees and that lymphokines present in the preparations are not involved in the antiviral effect of IFN. In addition, IFN-gamma preparation increases concanavalin A binding to L1210 S and L1210 R cells indicating that the sensitivity of L1210 R cells to IFN-gamma is not limited to its antiviral effect.

Full text

PDF
822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguet M., Belardelli F., Blanchard B., Marcucci F., Gresser I. High-affinity binding of 125I-labeled mouse interferon to a specific cell surface receptor. IV. Mouse gamma interferon and cholera toxin do not compete for the common receptor site of alpha / beta interferon. Virology. 1982 Mar;117(2):541–544. doi: 10.1016/0042-6822(82)90497-4. [DOI] [PubMed] [Google Scholar]
  2. Aguet M. High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature. 1980 Apr 3;284(5755):459–461. doi: 10.1038/284459a0. [DOI] [PubMed] [Google Scholar]
  3. Besancon F., Ankel H., Basu S. Specificity and reversibility of interferon ganglioside interaction. Nature. 1976 Feb 19;259(5544):576–578. doi: 10.1038/259576a0. [DOI] [PubMed] [Google Scholar]
  4. Falcoff E., Falcoff R., Lebleu B., Revel M. Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J Virol. 1973 Sep;12(3):421–430. doi: 10.1128/jvi.12.3.421-430.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Falcoff E., Wietzerbin J., Stefanos S., Lucero M., Billardon C., Catinot L., Besançon F., Ankel H. Properties of mouse immune T-interferon (type II). Ann N Y Acad Sci. 1980;350:145–156. doi: 10.1111/j.1749-6632.1980.tb20615.x. [DOI] [PubMed] [Google Scholar]
  6. Gresser I., Bandu M. T., Brouty-Boyé D. Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. J Natl Cancer Inst. 1974 Feb;52(2):553–559. doi: 10.1093/jnci/52.2.553. [DOI] [PubMed] [Google Scholar]
  7. Hovanessian A. G., La Bonnardiere C., Falcoff E. Action of murine gamma (immune)interferon on beta (fibroblast)-interferon resistant L 1210 and embryonal carcinoma cells. J Interferon Res. 1980 Fall;1(1):125–135. doi: 10.1089/jir.1980.1.125. [DOI] [PubMed] [Google Scholar]
  8. Interferon nomenclature. J Immunol. 1980 Nov;125(5):2353–2353. [PubMed] [Google Scholar]
  9. Landolfo S., Kirchner H., Simon M. M. Production of immune interferon is regulated by more than T cell subset: Lyt-1,2,3 and Qat-5 phenotypes of murine T lymphocytes involved in IFN-gamma production in primary and secondary mixed lymphocyte reaction. Eur J Immunol. 1982 Apr;12(4):295–299. doi: 10.1002/eji.1830120408. [DOI] [PubMed] [Google Scholar]
  10. Marcucci F., Waller M., Kirchner H., Krammer P. Production of immune interferon by murine T-cell clones from long-term cultures. Nature. 1981 May 7;291(5810):79–81. doi: 10.1038/291079a0. [DOI] [PubMed] [Google Scholar]
  11. Mogensen K. E., Bandu M. T., Vignaux F., Aguet M., Gressner I. Binding of 125I-labelled human alpha interferon to human lymphoid cells. Int J Cancer. 1981 Nov 15;28(5):575–582. doi: 10.1002/ijc.2910280508. [DOI] [PubMed] [Google Scholar]
  12. Stefanos S., Wietzerbin J., Huygen K., Falcoff E. Chromatographic behavior, purification, and properties of mouse BCG-induced gamma interferon. J Interferon Res. 1982;2(3):447–456. doi: 10.1089/jir.1982.2.447. [DOI] [PubMed] [Google Scholar]
  13. Van Damme J., De Ley M., Claeys H., Billiau A., Vermylen C., De Somer P. Interferon induced in human leukocytes by concanavalin A: isolation and characterization of gamma- and beta-type components. Eur J Immunol. 1981 Nov;11(11):937–942. doi: 10.1002/eji.1830111116. [DOI] [PubMed] [Google Scholar]
  14. Vaquero C., Sancéau J., Catinot L., Andreu G., Falcoff E., Falcoff R. Translation of mRNA from phytohemagglutinin-stimulated human lymphocytes: characterization of interferon mRNAs. J Interferon Res. 1982;2(2):217–228. doi: 10.1089/jir.1982.2.217. [DOI] [PubMed] [Google Scholar]
  15. Wietzerbin J., Falcoff E. General procedures for purification of mouse immune interferon. Methods Enzymol. 1981;78(Pt A):552–563. doi: 10.1016/0076-6879(81)78168-0. [DOI] [PubMed] [Google Scholar]
  16. Wietzerbin J., Stefanos S., Lucero M., Falcoff E., O'Malley J. A., Sulkowski E. Physico-chemical characterization and partial purification of mouse immune interferon. J Gen Virol. 1979 Sep;44(3):773–781. doi: 10.1099/0022-1317-44-3-773. [DOI] [PubMed] [Google Scholar]
  17. Youngner J. S., Salvin S. B. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol. 1973 Dec;111(6):1914–1922. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES